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Long-term Efficacy and Safety Study of Tacrolimus Combined with
Corticosteroids in the Treatment of Idiopathic Membranous Nephropathy
Dewei Zhang, Hongguang Zheng, L. I. Shang
The General Hospital of Shenyang Military Area Command, Shenyang, China
Objectives: To evaluate the long-term efficacy and safety of tacrolimus
(TAC) combined with corticosteroids in the treatment of idiopathic membra-
nous nephropathy patients. To study the relationship between TAC plasma
concentration and its efficacy and safety.
Methods: Eighty-one IMN patients with nephrotic syndrome were randomly
divided into two groups, TAC group (41) and CTX group (40). All patients
were given corticosteroids. The patients were followed-up for 24 months.
Results: After 24 months, the level of urinary protein excretion, ALB and TP
of the patients in these two groups were improved remarkably (p < 0.01).
After 6 months and 18 months, the total remission rate in TAC group was
higher than CTX group (p < 0.05). After 12 months and 24 months, the total
remission rate between these two groups was similar (p > 0.05). After 24
months, the complete remission rate in TAC group was higher than CTX group
(p < 0.05). After 18 months, the relapse rate in CTX group was higher than
TAC group (p < 0.05). The treatment efficacy for 6 months and 12 months
was positively correlated with TAC blood concentration (p < 0.05). The
treatment efficacy for 18 months and 24 months was not correlated with
TAC blood concentration (p > 0.05). At 6 months, 12 months, 18 months
and 24 months of TAC treatment, average blood concentrations were
5.65 ng/ml, 4.86 ng/ml, 2.83 ng/ml and 2.71 ng/ml, respectively. During
treatment, the incidence of abnormal glucose metabolism in the TAC group
was higher than in the CTX group (p < 0.05).
Conclusion: Short-term remission and long-term complete remission of using
TAC with corticosteroids were better than CTX in the treatment of idiopathic
membranous nephropathy. The relapse in the treatment of long-term and
low TAC dose was lower than with CTX.http://dx.doi.org/10.1016/j.hkjn.2015.09.0210223
Relationship Between Insulin Resistance and Radiographic Contrast
Nephropathy, and Forecasting the Effluence of Radiographic Contrast
Nephropathy in Patients with Insulin Resistance
Siyuan Teng
The Second Hospital of Dalian Medical University, Dalian, China
Objective: To confirm insulin resistance is the main liability factor of radio-
graphic contrast nephropathy. MMP-7 can forecast the effluence of radio-
graphic contrast nephropathy with insulin resistance.
Methods: There were 60 rats in total. 40 Wistar rats were randomly divided
into control group (fed with common diets) and model group (fed with high-
fat and high-sugar diets). They were then divided into three groups: control
group (CON group, n Z 20); contrast medium (iopamidol) induced nephrop-
athy group in normal rats (n Z 20); and contrast medium (iopamidol)
induced nephropathy group with insulin resistance rats (n Z 20). Rats
were sacrificed at 2 hours, 12 hours, 24 hours, 48 hours, and 72 hours. To
develop the model of contrast medium induced nephropathy, those rats
were pretreated with indomethacin (10 mg/kg) and L-NAME (10 mg/kg)
before administration of iopamidpl (3 g I/kg). The level of serum creatinine
was measured. The histopathologic degrees of renal tubular cell injury were
scored in HE-stained sections. The expressions of MMP-7 and mRNA in kidney
were semiquantitatively with immunohistochemistry, western blot and RT-
PCR, respectively.
Results: The level of serum creatinine in CM group with insulin resistance
displayed a significant increase at 24, 48 and 72 hours compared with that
in CON group and in CM group in normal rats (P < 0.05), so the rats model
had succeeded. Compared with CM group in normal rats, serum MMP-7
showed a significant increase in CM group with insulin resistance
(P < 0.05). In CM group with insulin resistance, histopathologic examinatoin
with HE revealed the different extents of acute tubular injury with tubular
brush border loss, which was more severe in medulla than in cortical tissue.
The semiquantitative renal tubular cell injury scores were increased in CM
group with insulin resistance (P < 0.05).
Conclusion: Expression of MMP-7 was increased in contrast medium iopami-
dol induced acute tubular cell injury model with insulin resistance, whichchanged earlier. MMP-7 can forecast the effluence of radiographic contrast
nephropathy with insulin resistance.http://dx.doi.org/10.1016/j.hkjn.2015.09.0220225
TRPC6 Involved in Glomerular Diseases via Up-regulating ILK
H. Zhang, X. Guo, T. Wang, J. Yang, J. Sun
Department of Nephrology, Tangdu Hospital, Fourth Military Medical
University, Xi’an, Shaanxi, China
Objective: Podocyte dysfunctions play a fundamental role in defective
glomerular filtration in many common forms of proteinuric kidney disorders.
It was reported that the abnormal of transient receptor potential cation
channel 6 (TRPC6), as well as up-regulating fibronectin (Fn) and matrix met-
alloproteinase-9 (MMP-9) via enhanced integrin-linked kinase (ILK) are
involved in podocytes injury, respectively. Whether there is correlation be-
tween TRPC6 and ILK in podocyte injury are not clear. We explored the
involvement of TRPC6 in the pathology of glomerular diseases via ILK.
Methods: Human glomerular biopsies were produced the consecutive
paraffin sections, and stained with anti-TRPC6 antibody and anti-ILK anti-
body respectively following standard protocals, including membranous ne-
phropathy (MN), focal segmental glomerulosclerosis (FSGS), diabetic
nephropathy (DN) and lupus nephritis (LN; Class V). Mouse podocyte clone
was cultured at 33C for proliferation and at 37C for differentiation. Podo-
cytes were treated with adriamycin (10e6M). TRPC6 were inhibited through
SKF96365 (TRPC6 channel inhibitors). TRPC6, ILK, ZO-1, Fn and MMP-9 were
detected by western blotting.
Results: TRPC6 and ILK expressions in MN, FSGS, DN and LN (Class V) were
higher than that in normal kidney tissue (P <0.05). There was positive cor-
relation between TRPC6 and ILK expression in focal segmental glomerulo-
sclerosis and diabetic nephropathy (r Z 0.906, P < 0.001; r Z 0.694,
P Z 0.004). After adriamycin treatment for 12 hours and 24 hours, TRPC6,
ILK, Fn and MMP9 increased markedly, and ZO-1 decreased (P <0.05). The
increases in ILK, Fn and MMP9, and the ZO-1 decrease were reduced by inhib-
iting TRPC6.
Conclusion: TRPC6 and ILK increases were observed in a variety of proteinu-
ric kidney disorders. Moreover, the increase in TRPC6, ILK, Fn and MMP9, and
the ZO-1 decrease were possibly involved in podocytes injury induced by
